Zentexia

Zen-C


Indication: Osteoarthritis 


Regulatory Category: Systemic Pharmaceutical


Chemistry: Novel small molecules optimized for systemic administration


Development stage: Preclinical


Lead candidates: ZN-4262, ZN-4265, ZN-4269


Pharmacodynamic profile: Confidential


Pharmacokinetic profile: Optimized for oral administration. Good distribution to relevant peripheral tissues.


Programs


Zen-A 


Indication: Chronic wounds and surgical wounds


Regulatory Category: Topical Pharmaceutical or Class 3 Medical Device


Chemistry: Novel small molecules optimized for topical application


Development stage: Preclinical


Lead candidates: ZN-2911, ZN-2913, ZN-2914


Pharmacodynamic profile: Confidential


Pharmacokinetic profile: Ideal compound solubility and distribution in the wound. Good penetration through relevant layers of the skin.

Zen-B


Indication: Dermatology (inflammation/ senescence)


Regulatory Category: Topical pharmaceutical / Skin care


Chemistry: Novel small molecules optimized for topical administration


Development stage: Preclinical


Lead candidates: ZN-3231, ZN-3244, ZN-3246


Pharmacodynamic profile: Confidential


Pharmacokinetic profile: Optimized for topical administration with good penetration into deeper layers of the skin.